EGFR and esophageal squamous cell carcinoma: Significant survival differences were observed between the EGFR high-expression group (including 24 ESCC patients in the top quadrant) and the EGFR low/medium-expression group (including 71 ESCC patients in the lower third quadrant) amongst all the ESCC patients in the dataset (Figure 1A).